These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6335073)

  • 1. Antimicrobial susceptibility, growth kinetic and pathogenicity of thymidine-requiring Streptococcus species.
    Fu KP; Kimble EF; Coldreck RJ; Konopka EA
    Chemotherapy; 1984; 30(6):373-8. PubMed ID: 6335073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility of enterococci to trimethoprim and trimethoprim-sulfamethoxazole.
    Crider SR; Colby SD
    Antimicrob Agents Chemother; 1985 Jan; 27(1):71-5. PubMed ID: 3920958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the in vitro activities of sulfamethoxazole and sulfadiazine combinations with trimethoprim.
    Kuipers JS
    Chemotherapy; 1979; 25(2):77-82. PubMed ID: 446188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exogenous thymidine and reversal of the inhibitory effect of sulfamethoxazole-trimethoprim on streptococci.
    Coll PF; Ausina VR; Vernis JV; Mirelis BO; Prats GP
    Eur J Clin Microbiol; 1984 Oct; 3(5):424-6. PubMed ID: 6238821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of minimal amounts of thymidine on activity of trimethoprim-sulfamethoxazole against Staphylococcus epidermidis.
    Jones C; Stevens DL; Ojo O
    Antimicrob Agents Chemother; 1987 Feb; 31(2):144-7. PubMed ID: 3494425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative inhibition of Haemophilus influenzae by trimethoprim/sulfamethoxazole.
    Pelton SI; Shurin PA; Klein JO; Finland M
    Antimicrob Agents Chemother; 1977 Dec; 12(6):649-54. PubMed ID: 303886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro.
    Hammerschlag MR
    Rev Infect Dis; 1982; 4(2):500-5. PubMed ID: 6981168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bactericidal activity "in vitro" of sulfamethoxazol-tri-methoprime (SMZ-TMP) alone and in combination with various antibiotics on bacterial strains isolated from urinary tract infections (author's transl)].
    Joly B; Chanal M; Sirot D; Cluzel R; Jouan JP
    Pathol Biol (Paris); 1979 Feb; 27(2):117-24. PubMed ID: 382045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elaboration of type b capsule by Haemophilus influenzae as a determinant of pathogenicity and impaired killing by trimethoprim-sulfamethoxazole.
    Yogev R; Moxon ER
    J Clin Invest; 1982 Mar; 69(3):658-65. PubMed ID: 6977557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole during hemodialysis.
    Nissenson AR; Wilson C; Holazo A
    Am J Nephrol; 1987; 7(4):270-4. PubMed ID: 3500644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.
    King CH; Shlaes DM; Dul MJ
    J Clin Microbiol; 1983 Jul; 18(1):79-83. PubMed ID: 6604070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall.
    Goodhart GL
    JAMA; 1984 Nov; 252(19):2748-9. PubMed ID: 6333522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Canine urinary tract infections: a comparison of in vitro antimicrobial susceptibility test results and response to oral therapy with ampicillin or with trimethoprim-sulfa.
    Ling GV; Rohrich PJ; Ruby AL; Johnson DL; Jang SS
    J Am Vet Med Assoc; 1984 Aug; 185(3):277-81. PubMed ID: 6332102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of sulphadiazine, sulphamethoxazole and trimethoprim in patients with varying renal function.
    Bergan T; Brodwall EK; Vik-Mo H; Anstad U
    Infection; 1979; 7 Suppl 4():S382-7. PubMed ID: 511352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.
    Hamilton DJ; Ulness BK; Baugher LK; Counts GW
    J Clin Microbiol; 1987 Oct; 25(10):1886-90. PubMed ID: 3312287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative pharmacokinetic study of four different sulfonamides in combination with trimethoprim in human volunteers.
    Garg SK; Ghosh SS; Mathur VS
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):23-5. PubMed ID: 3485584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical efficacy of prophylactic administration of trimethoprim/sulfadiazine in a Streptococcus equi subsp. zooepidemicus infection model in ponies.
    Ensink JM; Bosch G; van Duijkeren E
    J Vet Pharmacol Ther; 2005 Feb; 28(1):45-9. PubMed ID: 15720514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(3):140-6. PubMed ID: 378572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro synergy between sulfamethoxazole and trimethoprim on strains of Staphylococcus aureus sensitive and resistant to methicillin].
    Bismuth R; Jarlier V; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):429-33. PubMed ID: 6353335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.